• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021 - 2022年埃塞俄比亚部分地区急性发热疾病患者中流感和SARS-CoV-2病毒的临床及流行病学特征

Clinical and epidemiological characteristics of influenza and SARS-CoV-2 virus among patients with acute febrile illness in selected sites of Ethiopia 2021-2022.

作者信息

Chekol Musse Tadesse, Sugerman David, Tayachew Adamu, Mekuria Zelalem, Tesfaye Neamin, Alemu Aynalem, Gashu Andargachew, Shura Wolde, Gonta Melaku, Agune Admikew, Hailemariam Aster, Assefa Yonas, Wossen Mesfin, Hassen Abdulhafiz, Michele Parsons, Silver Rachel, Delelegn Hulemenaw, Briana Lozano, Kasa Tesfu, Kebede Nigatu

机构信息

Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

Front Public Health. 2025 Jul 9;13:1549159. doi: 10.3389/fpubh.2025.1549159. eCollection 2025.

DOI:10.3389/fpubh.2025.1549159
PMID:40703157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12283578/
Abstract

BACKGROUND

Viral respiratory pathogens have become the leading cause of acute undifferentiated febrile illness (AFI). We determined the fraction of AFI attributable to influenza and SARS-CoV-2 in Ethiopia, along with an understanding of their epidemiological characteristics.

METHODS

From February 2021 to June 2022, we enrolled patients meeting an AFI case definition (age >5 years with fever ≥38°C) who presented at one of four selected sentinel hospital sites in Jimma, Harari, Addis Ababa, and Gonder. Clinical and epidemiological information was collected, Nasopharyngeal swab samples were collected and analyzed using real-time PCR for respiratory viruses (influenza and SARS-CoV-2). A quasi-binomial regression model and multivariable regression were performed to compute fractions and establish associations with the agent detected.

RESULT

A total of 737 AFI cases were enrolled. The overall proportion of SARS-CoV-2, influenza A, and influenza B among AFI patients were 7.8, 1.9, and 0.5 per 100,000 population, respectively. Among the enrolled AFI cases tested for SARS-CoV-2 and Influenza virus, SARS-CoV-2 was the most detected pathogen with a positivity rate of 13.7% (95% CI:11.3-16.4), followed by influenza A and influenza B, which have a positivity rate of 3.3% (95% CI: 2.2-5.1) and 0.8% (95% CI:0.3-1.8), respectively. The positivity rate of SARS-CoV-2 peaked at 37.4% in September 2021. Per the multivariable analysis, cases ≥65 years of age were three [AOR = 3.3,95% CI:(1.9-5.7)] times more likely to be positive for SARS-CoV-2.

CONCLUSION

SARS-CoV-2 and influenza viruses were highly prevalent among AFI cases. The proportion of SARS-CoV-2 was higher among older adults. Further study is recommended to characterize influenza subtypes, SARS-CoV-2 variants and determine their attributable fraction among a broader panel of AFI-causing pathogens that contributes for guiding the proper diagnostics, treatment and surveillance measures.

摘要

背景

病毒性呼吸道病原体已成为急性未分化发热性疾病(AFI)的主要病因。我们确定了埃塞俄比亚AFI中归因于流感和新冠病毒的比例,并了解了它们的流行病学特征。

方法

2021年2月至2022年6月,我们纳入了符合AFI病例定义(年龄>5岁,发热≥38°C)且在吉姆马、哈拉里、亚的斯亚贝巴和贡德尔四个选定哨点医院之一就诊的患者。收集临床和流行病学信息,采集鼻咽拭子样本,并使用实时PCR检测呼吸道病毒(流感和新冠病毒)。进行了准二项回归模型和多变量回归分析,以计算比例并确定与检测到的病原体的关联。

结果

共纳入737例AFI病例。AFI患者中新冠病毒、甲型流感和乙型流感的总体比例分别为每10万人7.8、1.9和0.5例。在接受新冠病毒和流感病毒检测的AFI病例中,新冠病毒是检测到最多的病原体,阳性率为13.7%(95%CI:11.3 - 16.4),其次是甲型流感和乙型流感,阳性率分别为3.3%(95%CI:2.2 - 5.1)和0.8%(95%CI:0.3 - 1.8)。新冠病毒的阳性率在2021年9月达到峰值37.4%。根据多变量分析,≥65岁的病例感染新冠病毒呈阳性的可能性是[调整后比值比(AOR)= 3.3,95%CI:(1.9 - 5.7)]三倍。

结论

新冠病毒和流感病毒在AFI病例中高度流行。老年人中新冠病毒的比例更高。建议进一步研究以确定流感亚型、新冠病毒变体,并在更广泛的导致AFI的病原体中确定它们的归因比例,以指导适当的诊断、治疗和监测措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/03f4290fec3c/fpubh-13-1549159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/0dc7307e54e0/fpubh-13-1549159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/12c5e084c75a/fpubh-13-1549159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/03f4290fec3c/fpubh-13-1549159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/0dc7307e54e0/fpubh-13-1549159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/12c5e084c75a/fpubh-13-1549159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2e/12283578/03f4290fec3c/fpubh-13-1549159-g003.jpg

相似文献

1
Clinical and epidemiological characteristics of influenza and SARS-CoV-2 virus among patients with acute febrile illness in selected sites of Ethiopia 2021-2022.2021 - 2022年埃塞俄比亚部分地区急性发热疾病患者中流感和SARS-CoV-2病毒的临床及流行病学特征
Front Public Health. 2025 Jul 9;13:1549159. doi: 10.3389/fpubh.2025.1549159. eCollection 2025.
2
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率:2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
3
Epidemiology of respiratory syncytial virus and its subtypes among cases of influenza like illness and severe acute respiratory infection: findings from nationwide sentinel surveillance in Ethiopia.呼吸道合胞病毒及其亚型在流感样疾病和严重急性呼吸道感染病例中的流行病学:埃塞俄比亚全国哨点监测结果
BMC Infect Dis. 2025 Jul 24;25(1):941. doi: 10.1186/s12879-025-11330-6.
4
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023.2022年至2023年印度西孟加拉邦因严重急性呼吸道感染入院儿童中流感、呼吸道合胞病毒和新型冠状病毒2的流行病学及监测情况
BMC Infect Dis. 2025 Aug 20;25(1):1047. doi: 10.1186/s12879-025-11421-4.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
10
Post-pandemic surveillance of seven key respiratory pathogens using targeted next-generation sequencing (tNGS): A regional epidemiological study from Shandong, China.利用靶向二代测序(tNGS)对七种关键呼吸道病原体进行疫情后监测:来自中国山东的一项区域流行病学研究。
Diagn Microbiol Infect Dis. 2025 Oct;113(2):116931. doi: 10.1016/j.diagmicrobio.2025.116931. Epub 2025 May 27.

本文引用的文献

1
WHO declares the end of the COVID-19 global health emergency: lessons and recommendations from the perspective of ChatGPT/GPT-4.世界卫生组织宣布新冠疫情全球卫生紧急状态结束:基于ChatGPT/GPT-4视角的经验教训与建议
Int J Surg. 2023 Sep 1;109(9):2859-2862. doi: 10.1097/JS9.0000000000000521.
2
COVID-19 surveillance in Democratic Republic of Congo, Nigeria, Senegal and Uganda: strengths, weaknesses and key Lessons.刚果民主共和国、尼日利亚、塞内加尔和乌干达的 COVID-19 监测:优势、劣势和关键经验教训。
BMC Public Health. 2023 May 8;23(1):835. doi: 10.1186/s12889-023-15708-6.
3
SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia.
SARS-CoV-2 感染、临床特征及相关危险因素:在埃塞俄比亚西南部进行的首个 8 个月监测研究。
Inquiry. 2023 Jan-Dec;60:469580231166794. doi: 10.1177/00469580231166794.
4
COVID-19 has left the world less prepared for an influenza pandemic.新冠疫情让世界应对流感大流行的准备变得更少了。
Nat Med. 2023 May;29(5):1044-1045. doi: 10.1038/s41591-023-02340-5.
5
Challenges of acute febrile illness diagnosis in a national infectious diseases center in Rio de Janeiro: 16-year experience of syndromic surveillance.巴西里约热内卢国家传染病中心急性发热性疾病诊断的挑战:综合征监测 16 年经验。
PLoS Negl Trop Dis. 2023 Apr 3;17(4):e0011232. doi: 10.1371/journal.pntd.0011232. eCollection 2023 Apr.
6
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.2020年12月至2021年5月,肯尼亚三个健康与人口监测点的新冠病毒血清流行率
PLOS Glob Public Health. 2022 Aug 18;2(8):e0000883. doi: 10.1371/journal.pgph.0000883. eCollection 2022.
7
Epidemiology and Clinical Presentation of COVID-19 in Older Adults.老年人 COVID-19 的流行病学和临床表现。
Infect Dis Clin North Am. 2023 Mar;37(1):1-26. doi: 10.1016/j.idc.2022.11.001. Epub 2022 Nov 4.
8
Limitations of COVID-19 testing and case data for evidence-informed health policy and practice.新冠病毒检测和病例数据在循证卫生政策和实践方面的局限性。
Health Res Policy Syst. 2023 Jan 25;21(1):11. doi: 10.1186/s12961-023-00963-1.
9
Disappearance and Re-Emergence of Influenza during the COVID-19 Pandemic: Association with Infection Control Measures.新冠疫情期间流感的消失与重现:与感染控制措施的关联。
Viruses. 2023 Jan 13;15(1):223. doi: 10.3390/v15010223.
10
The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study.青少年 4CMenB 疫苗接种对英国淋病奈瑟菌感染的潜在公共卫生影响:一项建模研究。
BMC Public Health. 2023 Jan 10;23(1):1. doi: 10.1186/s12889-022-14670-z.